Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Switch to Generic Entecavir (Baracle) in Resistant CHB
NCT04069858Phase 4Unknown
- Sponsor
- Korea University
- Start
- Dec 2016
- Primary completion
- Mar 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of entecavir in Chronic Hepatitis B (CHB), sponsored by Korea University. Status: unknown.
02
Drugs
entecavir
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT04069858.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04069858.